BioVie Files to Sell 7.71M Shares of Common Stock for Holders

Seeking AlphaNov 22 06:36

BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference

GlobeNewswireNov 20 21:00

BioVie | 10-Q: Q1 2025 Earnings Report

SECNov 14 05:52 · Announcements

Express News | BioVie Inc - Pd-202 Trial Expected to Start Early 2025, Results by Late 2025

BreakingsNov 4 21:00

Express News | Biovie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded

BreakingsNov 4 21:00

(BIVI) - Analyzing BioVie's Short Interest

BenzingaNov 1 01:15